Day: July 28, 2022

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

The CDMO’s Milan facility provides lentiviral vector and autologous CD34+ cell-based drug products for clinical testing SEATTLE, MILAN, July 28, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new